BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 7995933)

  • 21. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
    Brocke P; Armandola E; Garbi N; Hämmerling GJ
    Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells.
    Reich M; Zou F; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
    Cell Immunol; 2011; 269(2):96-103. PubMed ID: 21543057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
    Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
    Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules.
    Kang SJ; Cresswell P
    EMBO J; 2002 Apr; 21(7):1650-60. PubMed ID: 11927549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
    Long EO; LaVaute T; Pinet V; Jaraquemada D
    J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
    Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
    J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments.
    Anderson HA; Bergstralh DT; Kawamura T; Blauvelt A; Roche PA
    J Immunol; 1999 Nov; 163(10):5435-43. PubMed ID: 10553069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular organelles involved in antigen processing and the binding of peptides to class II MHC molecules.
    Harding CV
    Semin Immunol; 1995 Dec; 7(6):355-60. PubMed ID: 8775461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells.
    West MA; Lucocq JM; Watts C
    Nature; 1994 May; 369(6476):147-51. PubMed ID: 8177319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments.
    Peters PJ; Neefjes JJ; Oorschot V; Ploegh HL; Geuze HJ
    Nature; 1991 Feb; 349(6311):669-76. PubMed ID: 1847504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invariant chain retains MHC class II molecules in the endocytic pathway.
    Loss GE; Sant AJ
    J Immunol; 1993 Apr; 150(8 Pt 1):3187-97. PubMed ID: 8468464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assembly of an abundant endogenous major histocompatibility complex class II/peptide complex in class II compartments.
    Morkowski S; Raposo G; Kleijimeer M; Geuze HJ; Rudensky AY
    Eur J Immunol; 1997 Mar; 27(3):609-17. PubMed ID: 9079799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes.
    Ramachandra L; Song R; Harding CV
    J Immunol; 1999 Mar; 162(6):3263-72. PubMed ID: 10092778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment.
    Harding CV; Geuze HJ
    J Immunol; 1993 Oct; 151(8):3988-98. PubMed ID: 8409381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular pathway for the generation of functional MHC class II peptide complexes in immature human dendritic cells.
    Saudrais C; Spehner D; de la Salle H; Bohbot A; Cazenave JP; Goud B; Hanau D; Salamero J
    J Immunol; 1998 Mar; 160(6):2597-607. PubMed ID: 9510157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
    Fineschi B; Sakaguchi K; Appella E; Miller J
    J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
    Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
    J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB.
    Copier J; Kleijmeer MJ; Ponnambalam S; Oorschot V; Potter P; Trowsdale J; Kelly A
    J Immunol; 1996 Aug; 157(3):1017-27. PubMed ID: 8757605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of transport of newly assembled, T cell-stimulatory MHC class II-peptide complexes from MHC class II compartments to the cell surface.
    Pond L; Watts C
    J Immunol; 1997 Jul; 159(2):543-53. PubMed ID: 9218568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
    Hitzel C; van Endert P; Koch N
    J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.